Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 520, pseudogene (RN7SL520P) is a human pseudogene located on chromosome 16, representing a nonfunctional, sequence-homologous copy of the functional 7SL RNA gene, which is associated with the signal recognition particle (SRP) responsible for targeting proteins to the endoplasmic reticulum. As a pseudogene, RN7SL520P itself does not produce a functional RNA or protein and does not participate in canonical biological or therapeutic processes. Pseudogenes such as this can complicate genetic analysis but generally have no direct biological activity. RN7SL520P is explicitly described as a pseudogene of 7SL RNA, meaning it does not encode a functional gene product. Pseudogenes are nonfunctional DNA segments that resemble functional genes; thus, they are not considered therapeutic targets, do not have direct biological functions, and are not implicated in disease mechanisms. The functional gene, 7SL RNA (RN7SL1), plays a critical role in protein targeting within the signal recognition particle complex, but RN7SL520P does not share this activity. There are no known drugs, mechanisms of action, biomarker significance, or safety concerns relevant to this specific pseudogene. The entry is technically accurate but not a therapeutically actionable target, marking it as "is_incorrect: true" concerning therapeutic relevance expectations. If you are seeking drug targets or disease markers, this entry should not be included.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 520, pseudogene (RN7SL520P).